Summary

● The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.


Strengths

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.01 for the 2023 fiscal year.

● The company's share price in relation to its net book value makes it look relatively cheap.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.

● Low profitability weakens the company.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 250.62 times its estimated earnings per share for the ongoing year.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.